Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Liao

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Gut|April 1, 1997
Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivoA Fasano, F R Noriega, F M Liao, et al.
The Journal of Infectious Diseases|November 1, 1995
Prevalence of Shigella enterotoxin 1 among Shigella clinical isolates of diverse serotypesF R Noriega, F M Liao, S B Formal, et al.
Infection and Immunity|August 1, 1996
Engineered deltaguaB-A deltavirG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity, and potential efficacy as a mucosal vaccineF R Noriega, G Losonsky, C Lauderbaugh, et al.
Infection and Immunity|January 23, 1999
Strategy for cross-protection among Shigella flexneri serotypesF R Noriega, F M Liao, D R Maneval, et al.
Shanghai Kou Qiang Yi Xue = Shanghai Journal of Stomatology|March 3, 2004
[Study on computer aided design system of anterior prosthesis in terms of artificial neural network]Y Q Wang, Z Wang, S L Yu, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Gut|April 1, 1997
Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivoA Fasano, F R Noriega, F M Liao, et al.
The Journal of Infectious Diseases|November 1, 1995
Prevalence of Shigella enterotoxin 1 among Shigella clinical isolates of diverse serotypesF R Noriega, F M Liao, S B Formal, et al.
Infection and Immunity|August 1, 1996
Engineered deltaguaB-A deltavirG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity, and potential efficacy as a mucosal vaccineF R Noriega, G Losonsky, C Lauderbaugh, et al.
Infection and Immunity|January 23, 1999
Strategy for cross-protection among Shigella flexneri serotypesF R Noriega, F M Liao, D R Maneval, et al.
Shanghai Kou Qiang Yi Xue = Shanghai Journal of Stomatology|March 3, 2004
[Study on computer aided design system of anterior prosthesis in terms of artificial neural network]Y Q Wang, Z Wang, S L Yu, et al.
Pageof 1